Optimizing the Size and Improving the Impact of Oncology Field-Based Medical Teams in Major Global Markets: Optimizing Staffing and Resources

STUDY OVERVIEW

To maximize the impact of oncology-focused field-based medical teams in high-potential global markets, organizations need to have staffing and resource levels that reflect the needs and opportunities of different regions. To provide current oncology field team staffing and resource metrics in North America, Europe and globally, Best Practices, LLC conducted this study to deliver benchmarks around staffing levels, resource allocations, and favored MSL backgrounds.

This study will help companies fill knowledge gaps around key operational areas for oncology-focused field medical teams, including staffing and resourcing in high-potential geographies. Leaders involved with field-based medical teams focused on oncology can utilize this study to create a road map for becoming more effective in high-potential global markets.

This study includes four segments: All Participants, North America, Europe (Germany and UK), and global (countries outside the US).

KEY TOPICS

• Executive Summary: Methodology, Participants, & Key Findings
• Optimal Field Team Staffing and Resourcing
  
  

• Total staff allocated to five roles: MSL, MSL manager, MSL effectiveness, HOL, HOL manager
• Total MSL staff compared to total HOL staff, on average
• On average, how many thought leaders do each of your MSLs support?
• What percentage of thought leaders served are HCPs versus KOLs?
• Do your field MSLs suport large key accounts (hospitals, etc.)?
• How many large key accounts does each MSL support, on average?
• How many payers do each of your MSLs support, on average?
• What percentage of the peak MSL team size, on average, are assigned to support a product at each product lifecycle phase?
• Percentage of your MSLs that have worked previously in the following roles?
• How effective are the following backgrounds for enabling your MSLs to engage thought leaders in high quality scientific discussions
• How many years of experience do your MSLs have, on average

• MSL Background: MSLs are most likely to have a pharmacist background (47%). MSLs with backgrounds as a scientist (38%) or physician (31%) are also common. Just 14% of MSLs are former nurses. U.S. field-medical teams make extensive use of pharmacists (56% of all MSLs), while EU5 field teams leverage scientists and physicians more heavily.

Overall, 20 field-based medical leaders and medical affairs executives participated in this benchmark research. These leaders provided field performance data and qualitative insights from a total of 15 Oncology pharma and biotech organizations.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Chemical; Manufacturing; Consumer Products; Diagnostic; Medical Device


Companies Profiled:
AstraZeneca; Daiichi Sankyo; Eisai; EMD Serono; Merck; Genentech; GlaxoSmithKline ; Shire; Janssen; Ipsen; Astellas; Amgen; Bayer; Roche; Merck Serono

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.